TUESDAY Feb. 4, 2014, 2014 -- In a first-of-its-kind initiative, the U.S. National Institutes of Health has partnered with 10 drug companies and several nonprofit groups to speed development of biological ways of diagnosing and treating ...
SeaChange Pharmaceuticals has introduced its similarity ensemble approach (SEA) software called SEAware for predictive matching of drugs with disease and toxicity targets. SEAware provides analysis and visualization tools for prediction ...
Tranzyme Pharma has completed the chemistry-based drug discovery partnership and transferred the resulting compounds to Bristol-Myers Squibb to advance the development. The strategic collaboration leveraged Macrocyclic Template Chemistry, ...
Tags: Tranzyme Pharma, chemistry based drug, chemistry technology, company news
Collaborative Drug Discovery (CDD) and SRI International have won a second grant from the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health, for the joint development of an ...
Tags: Collaborative Drug Discovery, CDD, tuberculosis, TB
GlaxoSmithKline (GSK) and Chiromics have partnered to discover classes of small molecules against biological targets. The collaboration will leverage Chiromics' compound collections of accessible complexity, Chalis, hit recognition ...
Tags: biological targets, classes of Small Molecules, drug discovery